NeoGenomics, Inc. (NEO)
NASDAQ: NEO · IEX Real-Time Price · USD
13.73
-0.20 (-1.44%)
Jul 2, 2024, 4:00 PM EDT - Market closed
NeoGenomics Market Cap
NeoGenomics has a market cap or net worth of $1.75 billion as of July 2, 2024. Its market cap has decreased by -15.32% in one year.
Market Cap
1.75B
Enterprise Value
1.98B
1-Year Change
-15.32%
Ranking
Category
Stock Price
$13.73
Market Cap Chart
Since March 16, 2004, NeoGenomics's market cap has increased from $7.90M to $1.75B, an increase of 22,096.02%. That is a compound annual growth rate of 30.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 1.75B | -14.98% |
| Dec 29, 2023 | 2.06B | 76.73% |
| Dec 30, 2022 | 1.17B | -72.22% |
| Dec 31, 2021 | 4.20B | -29.72% |
| Dec 31, 2020 | 5.98B | 95.74% |
| Dec 31, 2019 | 3.05B | 160.37% |
| Dec 31, 2018 | 1.17B | 64.64% |
| Dec 29, 2017 | 712.40M | 5.87% |
| Dec 30, 2016 | 672.90M | 41.66% |
| Dec 31, 2015 | 475.00M | 89.92% |
| Dec 31, 2014 | 250.10M | 41.06% |
| Dec 31, 2013 | 177.30M | 57.88% |
| Dec 31, 2012 | 112.30M | 85.62% |
| Dec 30, 2011 | 60.50M | 24.49% |
| Dec 31, 2010 | 48.60M | -12.90% |
| Dec 31, 2009 | 55.80M | 189.12% |
| Dec 31, 2008 | 19.30M | -43.07% |
| Dec 31, 2007 | 33.90M | -16.30% |
| Dec 29, 2006 | 40.50M | 841.86% |
| Dec 30, 2005 | 4.30M | -20.37% |
| Dec 31, 2004 | 5.40M | -31.65% |
| Mar 16, 2004 | 7.90M | - |
View and export this data all the way back to 2004.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LeMaitre Vascular | 1.83B |
| Rocket Pharmaceuticals | 1.81B |
| NovoCure | 1.81B |
| Novavax | 1.80B |
| Syndax Pharmaceuticals | 1.78B |
| Evotec SE | 1.74B |
| Immunocore Holdings | 1.73B |
| Edgewise Therapeutics | 1.71B |